These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India. Kumar A; Khan NM; Anikhindi SA; Sharma P; Bansal N; Singla V; Arora A World J Gastroenterol; 2017 Jan; 23(4):687-696. PubMed ID: 28216976 [TBL] [Abstract][Full Text] [Related]
28. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient. Jachs M; Hartl L; Simbrunner B; Semmler G; Balcar L; Hofer BS; Schwarz M; Bauer D; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M J Hepatol; 2024 May; 80(5):744-752. PubMed ID: 38218352 [TBL] [Abstract][Full Text] [Related]
29. MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension. Kennedy P; Stocker D; Carbonell G; Said D; Bane O; Hectors S; Abboud G; Cuevas J; Bolster BD; Friedman SL; Lewis S; Schiano T; Bhattacharya D; Fischman A; Thung S; Taouli B Eur Radiol; 2022 Dec; 32(12):8339-8349. PubMed ID: 35727321 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of Liver and Spleen Stiffness with Acoustic Radiation Force Impulse Quantification Elastography for Diagnosing Clinically Significant Portal Hypertension. Attia D; Schoenemeier B; Rodt T; Negm AA; Lenzen H; Lankisch TO; Manns M; Gebel M; Potthoff A Ultraschall Med; 2015 Dec; 36(6):603-10. PubMed ID: 26565516 [TBL] [Abstract][Full Text] [Related]
34. von Willebrand factor as a biomarker of clinically significant portal hypertension and severe portal hypertension: a systematic review and meta-analysis. Zou Z; Yan X; Li C; Li X; Ma X; Zhang C; Ju S; Tian J; Qi X BMJ Open; 2019 Aug; 9(8):e025656. PubMed ID: 31473610 [TBL] [Abstract][Full Text] [Related]
35. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
36. The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis. Reiberger T Hepatol Commun; 2022 May; 6(5):950-964. PubMed ID: 34904404 [TBL] [Abstract][Full Text] [Related]
37. High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic-associated fatty liver disease. Odriozola A; Puente Á; Cuadrado A; Iruzubieta P; Arias-Loste MT; Redondo C; Rivas C; Fábrega E; Crespo J; Fortea JI Liver Int; 2023 Jul; 43(7):1446-1457. PubMed ID: 36912787 [TBL] [Abstract][Full Text] [Related]
38. Comparison of three cut-offs to diagnose clinically significant portal hypertension by liver stiffness in chronic viral liver diseases: a meta-analysis. Song J; Ma Z; Huang J; Liu S; Luo Y; Lu Q; Schwabl P; Zykus R; Kumar A; Kitson M Eur Radiol; 2018 Dec; 28(12):5221-5230. PubMed ID: 29858640 [TBL] [Abstract][Full Text] [Related]
39. Shear Wave Elastography as a Quantitative Biomarker of Clinically Significant Portal Hypertension: A Systematic Review and Meta-Analysis. Suh CH; Kim KW; Park SH; Lee SS; Kim HS; Tirumani SH; Lee JG; Pyo J AJR Am J Roentgenol; 2018 May; 210(5):W185-W195. PubMed ID: 29570374 [TBL] [Abstract][Full Text] [Related]
40. Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension. Semmler G; Stift J; Scheiner B; Wöran K; Schwabl P; Paternostro R; Bucsics T; Stättermayer AF; Pinter M; Ferlitsch A; Trauner M; Reiberger T; Mandorfer M Dig Dis Sci; 2019 Dec; 64(12):3642-3651. PubMed ID: 31209721 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]